Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia.
Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.
Company Details
- Employees
- 5
- Founded
- 2015
- Address
- Imaging Centre Of Excellence, Queen Elizabeth University Hospital Campus, Langlands Road, Glasgow,glasgow G51 4lb,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aurumbioscience.com
- Keywords
- Representative jobs.
- HQ
- Glasgow, Glasgow
Aurum Biosciences Ltd Questions
Aurum Biosciences Ltd's website is aurumbioscience.com
Aurum Biosciences Ltd's LinkedIn profile is https://uk.linkedin.com/company/aurum-biosciences-ltd
Aurum Biosciences Ltd has
5 employees.
View email and phone details for 5
employees at Aurum Biosciences Ltd.
Aurum Biosciences Ltd's industry is
Biotechnology Research
Aurum Biosciences Ltd's top competitors are
Mironid® Limited,
Innoscot Health,
Genomics Jobs,
Enough,
Rawgene Biotech,
Clyde Biosciences,
Clintec,
Causeway Therapeutics,
Green Vision Scientific,
Aurum Biotech.
Aurum Biosciences Ltd's categories are Biotechnology Research
Aurum Biosciences Ltd's founding year is 2015
